West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin

By / / Finance / 1 minute of reading



im 15140884
West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for 2025 that was well below expectations.



Source link

About The Author

Avatar of Nicole Gould
Julia Hopkins is a news writer for The Pike Street Press, covering politics, health and business. She's also a mom who loves to travel and enjoys spending time with her family and friends.

Start typing and press enter to search

Scroll to Top